Eprosartan (CED0007477)

Record Information
Version1.0
Creation Date2016-05-25 03:24:43 UTC
Update Date2026-08-22 00:18:18 UTC
Accession NumberCHEM021328
Identification
Common NameEprosartan
ClassSmall Molecule
Description
Eprosartan is an organic compound with the formula C23H24N2O4S and an average molecular weight of 424.51 g/mol. Eprosartan belongs to the benzoic acids and derivatives, a subclass of benzene and substituted derivatives within the organic compounds. It functions as an antagonist of the Type-1 angiotensin II receptor (AGTR1). The compound is identified in three recorded sources: healthcare, pharmaceuticals & veterinary products (specifically angiotensin ii receptor blockers (arbs)), electrical & electronic equipment (antennas), and household cleaning & consumer products (non electric simulated smoking devices). The recorded route of exposure for this substance is oral.
Contaminant TypeNot Available
Chemical Structure
Synonyms
ValueSource
(e)-2-Butyl-1-(p-carboxybenzyl)-alpha-2-thenylimidazole-5-acrylic acidChEBI
(e)-3-[2-N-Butyl-1-{(4-carboxyphenyl)methyl}-1H-imidazol-5-yl]-2-(2-thienyl)methyl-2-propenoic acidChEBI
(e)-Alpha{[2-butyl-1-[(4-carboxyphenyl)methyl]-1H-imidazole-5-yl]methylene}-2-thiopheneproprionic acidChEBI
(e)-2-Butyl-1-(p-carboxybenzyl)-a-2-thenylimidazole-5-acrylateGenerator
(e)-2-Butyl-1-(p-carboxybenzyl)-a-2-thenylimidazole-5-acrylic acidGenerator
(e)-2-Butyl-1-(p-carboxybenzyl)-alpha-2-thenylimidazole-5-acrylateGenerator
(e)-2-Butyl-1-(p-carboxybenzyl)-α-2-thenylimidazole-5-acrylateGenerator
(e)-2-Butyl-1-(p-carboxybenzyl)-α-2-thenylimidazole-5-acrylic acidGenerator
(e)-3-[2-N-Butyl-1-{(4-carboxyphenyl)methyl}-1H-imidazol-5-yl]-2-(2-thienyl)methyl-2-propenoateGenerator
(e)-Alpha{[2-butyl-1-[(4-carboxyphenyl)methyl]-1H-imidazole-5-yl]methylene}-2-thiopheneproprionateGenerator
SK And F 108566HMDB
TevetenHMDB
Chemical FormulaC23H24N2O4S
Average Molecular Mass424.513 g/mol
Monoisotopic Mass424.146 g/mol
CAS Registry Number133040-01-4
IUPAC Name4-({2-butyl-5-[(1E)-2-carboxy-2-(thiophen-2-ylmethyl)eth-1-en-1-yl]-1H-imidazol-1-yl}methyl)benzoic acid
Traditional Nameeprosartan
SMILESCCCCC1=NC=C(\C=C(/CC2=CC=CS2)C(O)=O)N1CC1=CC=C(C=C1)C(O)=O
InChI IdentifierInChI=1S/C23H24N2O4S/c1-2-3-6-21-24-14-19(12-18(23(28)29)13-20-5-4-11-30-20)25(21)15-16-7-9-17(10-8-16)22(26)27/h4-5,7-12,14H,2-3,6,13,15H2,1H3,(H,26,27)(H,28,29)/b18-12+
InChI KeyOROAFUQRIXKEMV-LDADJPATSA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as benzoic acids. These are organic Compounds containing a benzene ring which bears at least one carboxyl group.
KingdomOrganic compounds
Super ClassBenzenoids
ClassBenzene and substituted derivatives
Sub ClassBenzoic acids and derivatives
Direct ParentBenzoic acids
Alternative Parents
Substituents
  • Benzoic acid
  • 1,2,5-trisubstituted-imidazole
  • Benzoyl
  • Imidazolyl carboxylic acid derivative
  • Trisubstituted imidazole
  • Dicarboxylic acid or derivatives
  • N-substituted imidazole
  • Azole
  • Heteroaromatic compound
  • Imidazole
  • Thiophene
  • Carboxylic acid derivative
  • Carboxylic acid
  • Azacycle
  • Organoheterocyclic compound
  • Hydrocarbon derivative
  • Organic nitrogen compound
  • Carbonyl group
  • Organic oxide
  • Organic oxygen compound
  • Organopnictogen compound
  • Organooxygen compound
  • Organonitrogen compound
  • Aromatic heteromonocyclic compound
Molecular FrameworkAromatic heteromonocyclic compounds
External Descriptors
Biological Properties
StatusDetected and Not Quantified
OriginNot Available
Cellular LocationsNot Available
Biofluid LocationsNot Available
Tissue LocationsNot Available
ApplicationsNot Available
Biological RolesNot Available
Chemical RolesNot Available
Organoleptic EffectsNot Available
Physical Properties
StateNot Available
AppearanceNot Available
Experimental Properties
PropertyValue
Melting PointNot Available
Boiling PointNot Available
SolubilityNot Available
Predicted Properties
PropertyValueSource
Water Solubility0.0087 g/LALOGPS
logP3.57ALOGPS
logP3.8ChemAxon
logS-4.7ALOGPS
pKa (Strongest Acidic)3.63ChemAxon
pKa (Strongest Basic)6.93ChemAxon
Physiological Charge-2ChemAxon
Hydrogen Acceptor Count5ChemAxon
Hydrogen Donor Count2ChemAxon
Polar Surface Area92.42 ŲChemAxon
Rotatable Bond Count10ChemAxon
Refractivity117.02 m³·mol⁻¹ChemAxon
Polarizability45.29 ųChemAxon
Number of Rings3ChemAxon
BioavailabilityYesChemAxon
Rule of FiveYesChemAxon
Ghose FilterYesChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleYesChemAxon
Spectra
Spectra
Spectrum TypeDescriptionSplash KeyDeposition DateView
Predicted GC-MSPredicted GC-MS Spectrumsplash10-0570-3319300000-aac3fe556775bf3acc88Not AvailableView Spectrum
Predicted GC-MSPredicted GC-MS Spectrumsplash10-0ufr-5011890000-afa379b8ab766fe48b4bNot AvailableView Spectrum
Predicted GC-MSPredicted GC-MS SpectrumNot AvailableNot AvailableView Spectrum
Predicted GC-MSPredicted GC-MS SpectrumNot AvailableNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-004i-0009000000-fa421ee23b907968b800Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-00di-0002900000-694c481f9555295f9426Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-004u-0289000000-647b9ea41a7a812dea66Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-00kg-0290000000-08e189bdaeb9c6af3b4fNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-014j-1290000000-e8207e65f017389d706fNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-00lr-9260000000-7b844b75045cf89e145eNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-001i-9100000000-f49fc8384f38dc7b6e3bNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-00di-0002900000-e62e6d74d830487d0954Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-002u-0198000000-d571b7bcdbe9e3f7e69fNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-00kp-0290000000-0b7c3fe664812ce51596Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-014j-1090000000-85f4ee357273ee0268c0Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-001i-9240000000-8ed6c4fadafd173a2579Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-001i-9400000000-81bd0b20c45458b1bdecNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-004i-0009000000-0333ac2f95788dceda2cNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0a4l-0196300000-c2476723863e5584d7e8Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-004i-0000900000-a93af7ff9cf5786971d0Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-056r-0171900000-4a8d34412967af4cbf35Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-052r-1971000000-ee85641cdce897ab6693Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-052r-1920000000-282ecc38e7c0c6cbefefNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0a4i-1900000000-1a109162fa90e4ce7932Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0a4i-2900000000-54946c90c1dfdf5eb21eNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-004i-0000900000-f33c4c2419ad566fa726Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-056r-1172900000-e0852717bfa6c5f8f0cdNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-052r-1970000000-fed4d418faa53031f6caNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-052r-1920000000-2ddeec1f39e95c27109dNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0a4r-1910000000-2953fc7d89567648d5eaNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0a4i-1900000000-1e52f8edbad114f026d5Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0a4l-0196300000-e398b1a8add5df82164bNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0a4l-0096300000-8b1a5e4d2167685c596aNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-014j-1290000000-e8207e65f017389d706fNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-00kg-0290000000-08e189bdaeb9c6af3b4fNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-00di-0002900000-e62e6d74d830487d0954Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-004i-0000900000-a93af7ff9cf5786971d0Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-056r-0171900000-e86ffce5de409aa901c5Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-002u-0198000000-d571b7bcdbe9e3f7e69fNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-004u-0289000000-647b9ea41a7a812dea66Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-056r-0172900000-2aa838d13d1677a480feNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-004i-0000900000-f33c4c2419ad566fa726Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-004i-0009000000-ca4588c9d813c9452da6Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-052r-1971000000-ee85641cdce897ab6693Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0a4l-0096300000-500d3e7a551d48660b52Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-00di-0002900000-694c481f9555295f9426Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-052r-1920000000-282ecc38e7c0c6cbefefNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-004i-0009000000-6671e2a591fcd6105b38Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-052r-1970000000-fed4d418faa53031f6caNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-052r-1920000000-2ddeec1f39e95c27109dNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-014j-1090000000-85f4ee357273ee0268c0Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-00kp-0290000000-0b7c3fe664812ce51596Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-056r-0007900000-af8b26b78a7236bf49ddNot AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-0bwd-0039200000-2d604267275eb14f1e11Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-001i-3079000000-c55b0efc1b2e86cb7aecNot AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-00fr-1008900000-930173837879467b7cbfNot AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-0059-2019200000-79382deb0cfe4928da7aNot AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-0a4j-9001000000-775d3beb00a39b27ce48Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-004i-0000900000-e026aec65c02c97a7b94Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-0a73-3504900000-c4fd60e2312745e66adfNot AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-0006-9601000000-21632835c564c2f97eccNot AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-00di-0002900000-3654d61760d81674741fNot AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-003g-4249100000-2428eb6978884165ae25Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-00e9-8193000000-bb9bb1cdbaa3fd5939d9Not AvailableView Spectrum
Toxicity Profile
Mechanism of ToxicityNot Available
Carcinogenicity (IARC Classification)Not Available
Minimum Risk LevelNot Available
SymptomsNot Available
TreatmentNot Available
Toxicity Values
Toxicity ValueUnitValue RangeOrganismDose DescriptorRoute of ExposurePredicted or ExperimentalReference
2357.0Log mg/kg[1300:4200]RatLD50oralpredictedNot Available
Health Effects
Health EffectRelationshipDirectionReference
Exposure Sources
Source IDSourceSectorReference
296Angiotensin ii receptor blockers (arbs)Healthcare, pharmaceuticals & veterinary productsNot Available
506AntennasElectrical & Electronic EquipmentNot Available
559Non Electric Simulated Smoking DevicesHousehold cleaning & consumer productsNot Available
Pathways
2 pathways
Targets
StructureProteinUniProt IDOrganismRelationshipDetails
Click to view 3D structureType-1 angiotensin II receptor BP29089Rattus norvegicusPredicted (SEA)1.32344
Click to view 3D structureType-2 angiotensin II receptorP35351Rattus norvegicusPredicted (SEA)1.16774
Type-1 angiotensin II receptor structureClick to view 3D structureType-1 angiotensin II receptorP30556HumansPredicted (SEA)3.58106
ATP-binding cassette sub-family C member 3 structureClick to view 3D structureATP-binding cassette sub-family C member 3O15438HumansPredicted (SEA)0.0778492
Click to view 3D structureType-1 angiotensin II receptorP25104Bos taurusPredicted (SEA)18.1389
Click to view 3D structureType-1 angiotensin II receptorP34976Oryctolagus cuniculusPredicted (SEA)21.3307
Click to view 3D structureComplement component 3a receptor 1, isoform CRA_aA8K2H7Homo sapiensPredicted (SEA)14.1686
Type-2 angiotensin II receptor structureClick to view 3D structureType-2 angiotensin II receptorP50052HumansPredicted (SEA)84.155
UDP-3-O-acyl-N-acetylglucosamine deacetylase structureClick to view 3D structureUDP-3-O-acyl-N-acetylglucosamine deacetylaseO67648Aquifex aeolicus (strain VF5)Predicted (SEA)47.3323
Carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1 structureClick to view 3D structureCarboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1Q9GZU7HumansPredicted (SEA)109.3
Click to view 3D structureType-1 angiotensin II receptor AP25095Rattus norvegicusPredicted (SEA)110.468
Estrogen receptor beta structureClick to view 3D structureEstrogen receptor betaQ92731HumansPredicted (SEA)181.544
Tyrosine-protein phosphatase non-receptor type 7 structureClick to view 3D structureTyrosine-protein phosphatase non-receptor type 7P35236HumansPredicted (SEA)142.231
Prostaglandin E2 receptor EP4 subtype structureClick to view 3D structureProstaglandin E2 receptor EP4 subtypeP35408HumansPredicted (SEA)113.271
Prostaglandin E2 receptor EP2 subtype structureClick to view 3D structureProstaglandin E2 receptor EP2 subtypeP43116HumansPredicted (SEA)103.929
Induced myeloid leukemia cell differentiation protein Mcl-1 structureClick to view 3D structureInduced myeloid leukemia cell differentiation protein Mcl-1Q07820HumansPredicted (SEA)569.389
Click to view 3D structureAngiotensinogenP01015Rattus norvegicusPredicted (SEA)22.9655
Prostaglandin E2 receptor EP3 subtype structureClick to view 3D structureProstaglandin E2 receptor EP3 subtypeP43115HumansPredicted (SEA)232.536
Click to view 3D structureProstaglandin E2 receptor EP1 subtypeP34995HumansPredicted (SEA)250.285
Peroxisome proliferator-activated receptor gamma structureClick to view 3D structurePeroxisome proliferator-activated receptor gammaP37231HumansPredicted (SEA)852.371
Click to view 3D structureProstaglandin E2 receptor EP4 subtypeP32240Mus musculusPredicted (SEA)101.671
Angiotensinogen structureClick to view 3D structureAngiotensinogenP01019HumansPredicted (SEA)14.0129
Cytochrome P450 2C9 structureClick to view 3D structureCytochrome P450 2C9P11712HumansPredicted (SEA)4521.48
Polyunsaturated fatty acid 5-lipoxygenase structureClick to view 3D structurePolyunsaturated fatty acid 5-lipoxygenaseP09917HumansPredicted (SEA)637.741
Tyrosine-protein phosphatase non-receptor type 1 structureClick to view 3D structureTyrosine-protein phosphatase non-receptor type 1P18031HumansPredicted (SEA)582.779
Concentrations
StatusValueUnitSample LocationReference
Detected and Quantified150ng/LBioggio,Lugano
Detected and Quantified750ng/LBussigny-prés-Lausanne
Detected and Quantified770ng/LHallau,Klettgau
Detected and Quantified100ng/LThal,Altenrhein
Detected and Quantified570ng/LUetendorf,Thun
Detected and Quantified300ng/LVernier,Aïre
Detected and Quantified460ng/LWerdhölzli,Zürich
Detected and Quantified19ng/LAffoltern,Zwillikon
External Links
DrugBank IDDB00876
HMDB IDHMDB0015014
FooDB IDNot Available
Phenol Explorer IDNot Available
KNApSAcK IDNot Available
BiGG IDNot Available
BioCyc IDNot Available
METLIN IDNot Available
PDB IDNot Available
Wikipedia LinkEprosartan
Chemspider ID4444504
ChEBI ID4814
PubChem Compound ID5281037
Kegg Compound IDC07467
YMDB IDNot Available
ECMDB IDNot Available
References
Synthesis ReferenceNot Available
MSDSNot Available
General References
1. Ruilope L, Jager B, Prichard B: Eprosartan versus enalapril in elderly patients with hypertension: a double-blind, randomized trial. Blood Press. 2001;10(4):223-9.
2. Hedner T: The clinical profile of the angiotensin II receptor blocker eprosartan. J Hypertens Suppl. 2002 Jun;20(5):S33-8.
3. Ruilope L, Jager B: Eprosartan for the treatment of hypertension. Expert Opin Pharmacother. 2003 Jan;4(1):107-14.
4. Puig JG, Lopez MA, Bueso TS, Bernardino JI, Jimenez RT: Clinical profile of eprosartan. Cardiovasc Drugs Ther. 2002 Dec;16(6):543-9.
5. de la Sierra A, Ram CV: Introduction: The pharmacological profile of eprosartan--implications for cerebrovascular and cardiovascular risk reduction. Curr Med Res Opin. 2007 Nov;23 Suppl 5:S1-3. doi: 10.1185/030079907X260692.
6. Blankestijn PJ, Rupp H: Clinical profile of eprosartan: a different angiotensin II receptor blocker. Cardiovasc Hematol Agents Med Chem. 2008 Oct;6(4):253-7.